Rixing Bio-Tech

Rixing Bio-Tech is a specialized biotechnology company focused on the development and large-scale production of nucleosides, nucleotides, and their derivatives. Based in Hubei, China, the company serves as a critical supplier and CDMO for the global pharmaceutical industry, particularly in the fields of antiviral and oncology therapeutics. Their product portfolio includes high-purity APIs and intermediates used in the synthesis of drugs for COVID-19, HIV, and Hepatitis. Rixing Bio-Tech leverages advanced enzymatic and chemical synthesis platforms to provide cost-effective solutions for complex molecule manufacturing. The company is recognized as a leading manufacturer of D-ribose and various modified ribose derivatives essential for modern drug discovery.